ZTS:NYSE
Zoetis Inc
83,71 $
arrow_downward
-0,13%(-0,11) 1 d.
16. nov., 15:09:21 GMT-5 · USD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: ZTS…
Atvērt
84,26 $
Augsta
84,57 $
Zema
83,18 $
Tirgus kapitalizācija
34,01 mljrd.
Vid. apjoms
4,43 milj.
Apjoms
1,93 milj.
Dividende
2,53%
Ceturkšņa dividendes
0,53 $
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 30. okt.
Cenas/peļņas attiecība
14,22
Augstākā 52 ned.
132,49 $
Zemākā 52 ned.
68,77 $
Peļņa uz vienu akciju
5,89 $
Beta
0,67
Apgrozībā esošās akcijas
406,32 milj.
Darbinieku skaits
14 tūkst.
Atvērt
84,26 $
Augsta
84,57 $
Zema
83,18 $
Tirgus kapitalizācija
34,01 mljrd.
Vid. apjoms
4,43 milj.
Apjoms
1,93 milj.
Dividende
2,53%
Ceturkšņa dividendes
0,53 $
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 30. okt.
Cenas/peļņas attiecība
14,22
Augstākā 52 ned.
132,49 $
Zemākā 52 ned.
68,77 $
Peļņa uz vienu akciju
5,89 $
Beta
0,67
Apgrozībā esošās akcijas
406,32 milj.
Darbinieku skaits
14 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
TradingView
·
pirms 5 stundām
ZTS: Pipeline launches and cost discipline underpin growth beyond a pressured 2027
Investing.com Canada
·
pirms 5 stundām
Zoetis at Jefferies Global Healthcare Conference: pipeline drives outlook By Investing.com
Profils
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
Par “Zoetis Inc”
ĢenerāldirektorsKristin C. Peck
Darbinieki14,5 tūkst.
Dibināšanas datums1952
Galvenais birojsParsippany-Troy Hills, Ņūdžersija, Amerikas Savienotās Valstis
SektorsHealth Care
Nozare-
Tīmekļa vietnezoetis.com